Skip to main content

2 Result(s)

within Daniel G. Stover Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. No Access

    Article

    Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience

    Purpose Capecitabine is widely used as a single agent on a 21-day cycle in the management of metastatic breast cancer (MBC). Our primary objective was to compare the standard dosing of capecitabine (Arm A: days 1...

    Anupama Suresh, Akannsha Ganju, Evan Morgan, Marilly Palettas… in Investigational New Drugs (2020)

  2. No Access

    Article

    Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer

    Purpose: To identify the maximum tolerated dose (MTD) and describe dose-limiting toxicities (DLT) of pemetrexed and oxaliplatin given on a once-every-2-week schedule in patients with meta...

    Daniel G. Stover, A. Craig Lockhart, Jordan D. Berlin… in Investigational New Drugs (2008)